The involvement of regulatory T cells (Tregs) in immune homeostasis is now recognized as one of the fundamental mechanisms of immune tolerance. While several different types of Tregs cooperate to establish and maintain immune homeostasis, much current research is focused on defining the characteristics of the CD4⁺CD25⁺ Treg subset, as these cells can mediate dominant, long-lasting and transferable tolerance in many experimental models. The aim of this research was to characterize the biological role of a protein known as forkhead box P3 (FOXP3) that was initially identified as an essential transcription factor for the development of mouse CD4⁺CD25⁺ Tregs, in human CD4⁺ T cells. Following confirmation that, like mouse Tregs, human Tregs also expressed high levels of FOXP3, several approaches were used to investigate the role of this protein in human CD4⁺ T cells. 1) Characterization of endogenous FOXP3 expression in CD4⁺ T cell subsets revealed that this protein is not a Treg-specific marker as was previously thought. Instead, low-level and transient expression was found to be typical of highly activated non-regulatory effector T cells. 2) To generate large numbers of Tregs suitable for cellular therapy, the capacity of ectopic FOXP3 expression to drive Treg generation in vitro was explored. It was found that high and constitutive expression mediated by a lentiviral vector, but not fluctuating expression driven by a retroviral vector, was sufficient to generate suppressive cells. Over-expression strategies were also used to characterize a novel splice isoform unique to human cells, FOXP3Δ2 (FOXP3b). 3) To further probe the requirements of FOXP3 to induce suppressor function, a system for conditionally-active FOXP3 ectopic expression was developed. These studies established that FOXP3 acts a quantitative regulator rather than a “master switch” for Tregs, and that there is a temporal component to its capacity to direct Treg phenotype and function. In summary, this research has significantly expanded the understanding of the biological function of FOXP3 in human CD4⁺ T cells. Based on the potential of these cells to be manipulated for therapy, this work contributes to the field of immunology on both academic and clinical research fronts.

The involvement of regulatory T cells (Tregs) in immune homeostasis is now recognized as one of the fundamental mechanisms of immune tolerance. While several different types of Tregs cooperate to establish and maintain immune homeostasis, much current research is focused on defining the characteristics of the CD4⁺CD25⁺ Treg subset, as these cells can mediate dominant, long-lasting and transferable tolerance in many experimental models. The aim of this research was to characterize the biological role of a protein known as forkhead box P3 (FOXP3) that was initially identified as an essential transcription factor for the development of mouse CD4⁺CD25⁺ Tregs, in human CD4⁺ T cells. Following confirmation that, like mouse Tregs, human Tregs also expressed high levels of FOXP3, several approaches were used to investigate the role of this protein in human CD4⁺ T cells. 1) Characterization of endogenous FOXP3 expression in CD4⁺ T cell subsets revealed that this protein is not a Treg-specific marker as was previously thought. Instead, low-level and transient expression was found to be typical of highly activated non-regulatory effector T cells. 2) To generate large numbers of Tregs suitable for cellular therapy, the capacity of ectopic FOXP3 expression to drive Treg generation in vitro was explored. It was found that high and constitutive expression mediated by a lentiviral vector, but not fluctuating expression driven by a retroviral vector, was sufficient to generate suppressive cells. Over-expression strategies were also used to characterize a novel splice isoform unique to human cells, FOXP3Δ2 (FOXP3b). 3) To further probe the requirements of FOXP3 to induce suppressor function, a system for conditionally-active FOXP3 ectopic expression was developed. These studies established that FOXP3 acts a quantitative regulator rather than a “master switch” for Tregs, and that there is a temporal component to its capacity to direct Treg phenotype and function. In summary, this research has significantly expanded the understanding of the biological function of FOXP3 in human CD4⁺ T cells. Based on the potential of these cells to be manipulated for therapy, this work contributes to the field of immunology on both academic and clinical research fronts.

Thesis (Ph.D.) -- University of Adelaide, Dept. of Paediatrics, 2004. / "March 2004" Includes bibliographical references (leaves 213-272).

Nosso objetivo, neste trabalho, foi verificar se a interação das células dendríticas (DCs) com antígenos da Hsp60 induz um efeito sinérgico no direcionamento de uma resposta imune reguladora, no sistema humano. Células dendríticas humanas maduras (mDC) e imaturas (iDC e iDC IL-10) foram geradas, in vitro, a partir de monócitos de 15 de indivíduos saudáveis. Estas células foram caracterizadas quanto à (i) morfologia, (ii) imunofentotipagem, (iii) produção de citocinas e, (iv) capacidade de estimular aloproliferação. Analisamos a auto-reatividade de linfócitos T (LT) dirigida a diferentes DCs (mDC, iDC e iDC IL-10). Na interação de antígenos da Hsp60 com essas diferentes DCs, verificamos: (i) a capacidade de induzir a produção de citocinas pelas DCs e de inibir a sua produção espontânea, (ii) a auto-reatividade de linfócitos T dirigida a esses antígenos (proliferação e produção de citocinas), (iii) a expressão gênica de um painel de moléculas reguladoras (TGFb, receptor de TGF-b, IL-10 e GATA3) e inflamatórias (IFNg, TNF-a e T-bet) em linfócitos, T no contexto de células dendríticas imaturas. As mDC apresentaram expressão de CD83, maior expressão de CD80, e CD86, assim como induziram respostas alogenéicas mais intensas do que as DCs imaturas. Apesar de haver variabilidade na produção de citocinas, apenas as DC imaturas produziram espontaneamente IL-10, e as DCs maduras produziram mais freqüentemente IFN-g e TNF-a. Analisando o efeito dos antígenos da Hsp60 sobre a produção de citocinas, observamos tanto indução quanto inibição da produção de IFN-g, TNF-a, IL-4 e IL-10 nos três grupos de DC. Porém, a inibição predominou sobre a produção nos três grupos de DC. A auto-reatividade proliferativa de LT dirigida às diferentes DCs foi mais freqüente nas culturas com as DCs maduras (6/10) do que com as DCs imaturas (4/10). Também detectamos produção das citocinas IFN-g, TNF-a, e IL-2 para todos os grupos de células, porém, mais freqüentemente na auto-reatividade contra as DCs maduras. Diversos antígenos da Hsp60 foram capazes de inibir esta auto-reatividade. O peptídeo N7 teve um efeito dominante na inibição da auto-reatividade proliferativa de linfócitos T dirigida às mDCs. A auto-reatividade a antígenos da Hsp60, de um modo geral, foi maior com as DCs imaturas. Diversos antígenos foram capazes de induzir proliferação e produção de citocinas. Todavia, o peptídeo C3 foi imunodominante (6/10) na indução de resposta linfoproliferativa, no contexto das iDCs. A expressão gênica de moléculas reguladoras e inflamatórias foi verificada em linfócitos T, na auto-reatividade a antígenos da Hsp60. Observamos modificações importantes de praticamente todas as moléculas estudadas. Verificamos um predomínio de modificações reguladoras para os genes TGFb, TGF-bR, GATA3, TNF-a e T-bet. O peptídeo N7 induziu modificações dominantemente reguladoras em todas as condições em que ele foi testado. Em conclusão, verificamos que antígenos da Hsp60 têm efeito direto na produção de citocinas das diferentes DCs. Também têm a capacidade de ativar, simultaneamente, em linfócitos T, na interação com as células dendríticas, genes funcionalmente antagônicos. Isto reafirma a diversidade funcional da Hsp60. Ademais, identificamos o peptídeo N7 como potencialmente imunorregulador e o consideramos um candidato a ser testado em protocolos para indução de tolerância. / The aim of the present study was to determine whether the interaction of dendritic cells (DCs) with antigens derived from Hsp60 is capable of inducing a synergistic effect in directing a regulatory immune response, using a human system. Human DCs with mature (mDC) and immature (iDC and iDC IL-10) phenotype were generated in vitro from monocytes obtained from 15 healthy subjects. These cells were characterized according to (i) morphology, (ii) expression of surface markers, (iii) cytokine production, and (iv) ability to stimulate alloproliferation. We analyzed the autoreactivity of T lymphocytes (TL) directed against different DC types (mDC, iDC, and iDC IL-10). For the interaction of Hsp60 antigens with these different DCs, we determined: (i) the ability to induce cytokine production by DCs as well as to inhibit their spontaneous production, (ii) the autoreactivity of TL to these antigens (proliferation and cytokine production), and (iii) gene expression levels of a panel of regulatory (TGFb, TGF-b receptor, IL-10, and GATA3) and inflammatory (IFN-g, TNF-a, and T-bet) molecules by TL when stimulated by mDC. mDC expressed CD83 and showed higher levels of CD80 and CD86 and induced stronger allogeneic responses than immature DCs. Although cytokine production varied, only immature DCs spontaneously produced IL- 10, and mature DCs more frequently produced IFN- and TNF-. An analysis of the effects of Hsp60 antigens on cytokine production showed both induction and inhibition of production of IFN-g, TNF-a, IL-4, and IL-10 by the three sets of DCs; however, inhibition predominated over induction in all three DC groups. The proliferative autoreactivity of LT directed towards the different DCs was more frequent in cultures containing mDCs (6/10) than in those containing immature DCs (4/10). We also detected production of IFN-g, TNFa, and IL-2 by all groups of cells; however this was more frequent in the context of autoreactivity against mDCs. Several Hsp60 antigens were capable of inhibiting this autoreactivity. Peptide N7 had a dominant effect on the inhibition of the proliferative autoreactivity of LT directed towards mDCs. Autoreactivity to Hsp60 antigens was generally greater in cultures containing immature DCs. Several antigens were capable of inducing proliferation and cytokine secretion. However, peptide C3 was immunodominant (6/10) in the induction of a lymphoproliferative response in cultures containing iDCs. Gene expression of regulatory and inflammatory molecules was determined in LTs in the context of autoreactivity to Hsp60 antigens. There were important modifications in virtually all molecules studied. There was a predominance of regulatory-oriented changes in expression of TGFb, TGF-bR, GATA3, TNFa, and T-bet. Peptide N7 induced dominantly regulatory changes in gene expression in all conditions in which it was tested. In conclusion, we have shown that Hsp60 antigens have a direct effect on cytokine production by different DCs. These antigens are also able to activate, during the interaction of LT with DCs, genes that are functionally antagonistic. This finding reinforces the functional diversity of Hsp60. Furthermore, we have identified peptide N7 as potentially immunoregulatory, and consider it as a candidate to be tested in protocols for the induction of tolerance.

This study compared the relative efficacy of four imagery techniques in increasing tolerance to cold pressor pain. Relevant pleasant, relevant unpleasant, irrelevant pleasant, and irrelevant unpleasant imagery strategies were compared in a two-way factorial design. Prior research suggested that pleasantness and relevance both affect imagery potency. This study attempted to assess the relative contribution of these two variables to increases in pain tolerance. Also investigated were the roles of several hypothesized mediating variables; namely, contextual valence, self-efficacy, treatment credibility, and involvement in imagery. The subjects were 60 female undergraduates who were randomly assigned to the four imagery groups. Two-way analysis of covariance were performed on all dependent variables, using pain threshold as the covariate. Pearons r.'s were used to test correlational hypotheses.

The involvement of regulatory T cells (Tregs) in immune homeostasis is now recognized as one of the fundamental mechanisms of immune tolerance. While several different types of Tregs cooperate to establish and maintain immune homeostasis, much current research is focused on defining the characteristics of the CD4⁺CD25⁺ Treg subset, as these cells can mediate dominant, long-lasting and transferable tolerance in many experimental models. The aim of this research was to characterize the biological role of a protein known as forkhead box P3 (FOXP3) that was initially identified as an essential transcription factor for the development of mouse CD4⁺CD25⁺ Tregs, in human CD4⁺ T cells. Following confirmation that, like mouse Tregs, human Tregs also expressed high levels of FOXP3, several approaches were used to investigate the role of this protein in human CD4⁺ T cells. 1) Characterization of endogenous FOXP3 expression in CD4⁺ T cell subsets revealed that this protein is not a Treg-specific marker as was previously thought. Instead, low-level and transient expression was found to be typical of highly activated non-regulatory effector T cells. 2) To generate large numbers of Tregs suitable for cellular therapy, the capacity of ectopic FOXP3 expression to drive Treg generation in vitro was explored. It was found that high and constitutive expression mediated by a lentiviral vector, but not fluctuating expression driven by a retroviral vector, was sufficient to generate suppressive cells. Over-expression strategies were also used to characterize a novel splice isoform unique to human cells, FOXP3Δ2 (FOXP3b). 3) To further probe the requirements of FOXP3 to induce suppressor function, a system for conditionally-active FOXP3 ectopic expression was developed. These studies established that FOXP3 acts a quantitative regulator rather than a “master switch” for Tregs, and that there is a temporal component to its capacity to direct Treg phenotype and function. In summary, this research has significantly expanded the understanding of the biological function of FOXP3 in human CD4⁺ T cells. Based on the potential of these cells to be manipulated for therapy, this work contributes to the field of immunology on both academic and clinical research fronts. / Medicine, Faculty of / Medicine, Department of / Experimental Medicine, Division of / Graduate

Indiana University-Purdue University Indianapolis (IUPUI) / Tolerance mechanisms, which collectively work to prevent autoimmunity, play a key role in suppressing the adaptive immune response to tumor antigens. This phenomenon is attributed to the extensive overlap of tumor associated antigens with self peptides. We studied immune tolerance to tumor antigen TRP-1, a melanoma associated glycoprotein. Vaccination of Wild type (WT) and TRP-1 deficient (Bw) mice with TRP-1 antigen highlighted the substantial effect of tolerance on the T cell response: in the Bw population a log-fold differential was observed with greater clonal numbers and higher intensity of cytokine release from the antigen specific CD4+ T cell population. Additionally, TRP-1-reactive T cells derived from Bw mice demonstrated significantly more efficacious tumor treatment ability than WT donor cells when adoptively transferred into recipients challenged with B16 melanoma. Furthermore, donor Bw T cells were so potent as to overcome suppression by endogenous Tregs in mediating their effect. Probing for a tolerance mechanism, we isolated medullary thymic epithelial cells (mTECs) from WT mice and found that they promiscuously express TRP-1. Unexpectedly, TRP-1 expression in mTECs was found to occur independently of the prominent Autoimmune Regulator (Aire) transcription factor as well as the melanocyte specific transcription factor, mMitf. Our most recent data suggests that thymic dendritic cells may also express copies of the TRP-1 transcript. Future transplant studies will test whether mTECs or thymic dendritic cells directly tolerize TRP-1 specific T cells. Overall, these findings highlight the relevance of central tolerance to cancer immunology and compel further investigation of its mechanistic impact on the development of tumor-reactive T cells.bb

INTRODUÇÃO: A indução de tolerância oral atenua a resposta inflamatória e a produção de anticorpos anafiláticos secundários presentes em quadros alérgicos pulmonares tanto em humanos quanto em modelos experimentais. Nestas situações, a modulação do remodelamento brônquico e o papel do óxido nítrico não foram previamente estudados. OBJETIVOS: 1. Desenvolver dois modelos de tolerância oral em cobaias com inflamação crônica pulmonar caracterizando: mecânica pulmonar, hiper-responsividade a metacolina, óxido nítrico exalado (NOex), anticorpos IgG1, inflamação brônquica e eosinofilopoiese. 2. Avaliar o remodelamento brônquico e a expressão da enzima óxido nítrico sintase neuronal (nNOS) no epitélio brônquico nestes animais. MÉTODOS: As cobaias receberam inalações de ovoalbumina ou soro fisiológico durante 15 minutos ou até que apresentassem desconforto respiratório (este tempo foi denominado tempo de inalação). O protocolo foi repetido duas vezes por semana durante quatro semanas. Para a indução da tolerância foi administrada ovoalbumina a 2% por via oral e oferecida ad libitum, sendo formados os grupos: 1. TO1 (recebeu ovoalbumina oral a 2% a partir da primeira inalação com ovoalbumina); 2. TO2 (recebeu ovoalbumina oral a 2% a partir da quarta inalação com ovoalbumina); 3. SAL (recebeu água ad libitum e inalações com soro fisiológico); 4. OVA (recebeu água ad libitum e inalações com solução de ovoalbumina). Após os animais serem anestesiados e ventilados, foram avaliados: 1. mecânica pulmonar basal e após inalação com ovoalbumina (30mg/ml) ou soro fisiológico, 2. hiper-responsividade brônquica à metacolina, 3. coletado o NOex. Ao final do experimento, os fragmentos pulmonares foram retirados e corados com hematoxilina e eosina, com a técnica histoquímica cianeto resistente para peroxidase eosinofílica (células EPO+), com a técnica imunoistoquímica para a detecção da óxido nítrico sintase neuronal (nNOS) e com resorcina-fucsina, resorcina-fucsina oxidada e picro-sírius. A medula óssea foi retirada e corada com hematoxilina e eosina. O índice de edema peribrônquico, as células EPO+, os mononucleares e os polimorfonucleares brônquicos e os eosinófilos da medula óssea foram avaliados por morfometria. As células epiteliais brônquicas nNOS+ e as fibras elásticas e colágenas foram avaliadas por densitometria óptica. Os anticorpos IgG1 foram detectados por anafilaxia cutânea passiva. A análise estatística foi feita com o programa SigmaStat e considerado significante um P<0,05. RESULTADOS: Nos grupos TO1 e TO2 houve aumento no tempo de inalação, diminuição na resposta máxima de elastância do sistema respiratório após desafio antigênico e com metacolina, diminuição do edema peribrônquico, dos eosinófilos, dos polimorfonucleares, das fibras elásticas e colágenas, da eosinofilopoiese e dos títulos de IgG1 (P < 0,05). Os mononucleares, a resposta máxima de resistência do sistema respiratório depois do desafio antigênico, e a metacolina diminuíram em TO2 (P < 0,05). O NOex e a percentagem de células epiteliais nNOS+ não foram alterados nos grupos tolerizados. CONCLUSÕES: A indução de tolerância oral concomitante ao início da sensibilização ou depois de estabelecida a resposta alérgica foi capaz de atenuar a inflamação eosinofílica, os títulos de IgG1 e o remodelamento brônquico presentes neste modelo de inflamação crônica pulmonar. A redução dos linfomononucleares e da hiper-responsividade brônquica foi mais efetiva quando a indução de tolerância foi feita em animais previamente sensibilizados. A dissociação entre o controle da inflamação eosinofílica e a avaliação do NOex e da expressão da nNOS no epitélio brônquico sugere um mecanismo novo ativado pela indução de tolerância oral / INTRODUCTION: The oral tolerance induction attenuates the inflammatory response and the production of secondary anaphylactic antibodies present in pulmonary allergy pictures in humans as well as in experimental models. In these situations, the bronchial remodeling modulation and the role of nitric oxide have not been previously studied. OBJECTIVES: 1. To develop two models of oral tolerance in guinea pigs with chronic pulmonary inflammation, characterizing: pulmonary mechanics, hyperreponsiveness to methacholine, exhaled nitric oxide (NOex), IgG1 antibodies, bronchial inflammation and eosinophylopoiesis. 2. To evaluate the bronchial remodeling and the expression of the neuronal nitric oxide synthase enzyme (nNOS) in bronchial epithelium of these animals. METHODS: The guinea pigs were submitted to ovalbumin or saline solution inhalation for 15 minutes or until they presented respiratory stress (this time period was called inhalation time). The protocol was repeated twice a week for 4 weeks. Oral tolerance induction was carried out by the administration of 2% oral ovalbumin, offered ad libitum, and the following groups were formed: 1. OT1 (received 2% oral ovalbumin from the first ovalbumin inhalation; 2. OT2 (received 2% oral ovalbumin from the fourth ovalbumin inhalation; 3. SAL (received water ad libitum and saline solution inhalations; and 4. OVA (received water ad libitum and ovalbumin solution inhalations). After being anesthetized, the animals were ventilated and evaluated regarding: 1. basal pulmonary mechanics and after ovalbumin (30mg/ml) or saline solution inhalation; 2. bronchial hyperresponsiveness to methacholine; and 3. NOex was collected. At the end of the experiment, the pulmonary fragments were removed and stained with hematoxylin-eosin, with the cyanide-resistant eosinophilic peroxidase histochemical technique (EPO+ cells), with the immunohistochemical technique for the detection of neuronal nitric oxide synthase (nNOS) and with Resorcin-fuchsin, Resorcin-fuchsin with oxidation and Picrosirius. The bone marrow was removed and stained with hematoxylin-eosin. The index of peribronchial edema, the EPO+ cells, the bronchial mononuclear and polymorphonuclear cells and the eosinophils from the bone marrow were evaluated by morphometry. The epithelial bronchial nNOS+ cells and the elastic and collagen fibers were evaluated by optical densitometry. IgG1 antibodies were detected by Passive Skin Anaphylaxis. Statistical analysis was performed with the SigmaStat software program and a P value < 0.05 was considered significant. RESULTS: The OT1 and OT2 groups showed increased inhalation time, decrease in the maximum elastance response of the respiratory system after the antigenic challenge and with methacholine, decrease of peribronchial edema, eosinophils, polymorphonuclear, elastic and collagen fibers, eosinophylopoiesis, and IgG1 titers (P < 0.05). The mononuclear cells, the maximum resistance response of the respiratory system after the antigenic challenge and methacholine decreased in OT2 (P < 0.05). NOex and the percentage of nNOS+ epithelial cells were not altered in the tolerized groups. CONCLUSIONS: The oral tolerance induction concomitant to the start of sensitization or after the allergic response has been established, was capable of attenuating the eosinophilic inflammation, IgG1 titers and the bronchial remodeling present in this model of chronic pulmonary inflammation. The decrease in lymphomononuclear cells and bronchial hyperresponsiveness was more effective when the tolerance induction was carried out in animals that had been previously sensitized. The dissociation between the eosinophilic inflammation and NOex evaluation and the expression of nNOS in the bronchial epithelium suggests a new mechanism activated by the oral tolerance induction

INTRODUÇÃO: As proteínas de choque térmico (HSPs) são proteínas presentes em todos os seres vivos. Elas possuem dupla atividade imunológica, induzindo tanto respostas proinflamatórias quanto imunorreguladoras. Em nosso grupo, estudamos os efeitos imunológicos dos peptídeos da HSP60 nos sistemas humano e murino. OBJETIVOS: Identificar peptídeos da HSP60 potencialmente imunorreguladores no sistema murino, visando a indução de tolerância no contexto do alotransplante. MÉTODOS: Analisamos a capacidade dos diferentes peptídeos de modificar, in vitro a expressão de genes predominantemente imunorreguladores (Foxp3, Gata-3, IDO, IL-4, IL-10, TGF?) ou inflamatórios (T-bet, IL-12p35, IL-12p40, IL-17) por PCR de tempo real, em esplenócitos murinos de animais naive. Consideramos as modificações induzidas pelos peptídeos como REGULA (?expressão de genes imunorreguladores ou ?expressão de genes inflamatórios) ou INFLAMA (?expressão de genes imunorreguladores ou ? expressão de genes inflamatórios). Selecionamos peptídeos que induziram predomínio de modificação da expressão gênica do tipo REGULA, mais promissores como imunorreguladores para ensaios in vivo de indução de tolerância ao aloenxerto de pele murino. RESULTADOS: Os peptídeos mais promissores foram N7, C4, N6, I8, N2 e N3. O peptídeo N7(n=9) induziu uma razão REGULA/INFLAMA=2,71 e induziu a redução da expressão gênica relativa de IL-17 e IL-12p40. O peptídeo C4 (n=6) induziu razão REGULA/INFLAMA=1,63 e induziu redução da expressão gênica relativa de IL-17 e IL-12p40. O peptídeo N6 (n=8) induziu uma razão REGULA/INFLAMA=1,60, induziu a redução da expressão gênica relativa de T-bet e IL-12p40 e aumentou a expressão de IL-10. O peptídeo I8 (n=5) induziu razão REGULA/INFLAMA=1,57 e induziu aumento da expressão gênica relativa de IL-17. O peptídeo N2 (n=8) induziu razão REGULA/INFLAMA=1,32 e induziu redução da expressão gênica relativa de IL-17 e aumento da expressão de IL-10, IL-4 e T-bet. O peptídeo N3 (n=7) induziu razão REGULA/INFLAMA=1,25 e não teve destaques na modificação gênica induzida. O peptídeo N7 foi testado em protocolos para indução de tolerância do alotransplante de pele murino. Não houve diferença estatística entre os diferentes grupos, a despeito do aumento de sobrevida do aloenxerto de 7 dias no protocolo em combinação com o anticorpo ?CD3 (p=0,38, n=5). DISCUSSÃO E CONCLUSÃO: O forte impacto imunorregulador de alguns peptídeos da HSP60 na expressão gênica de moléculas imunológicas indica que eles podem ser explorados em imunoterapias. Apesar da existência de variabilidade individual, o peptídeo N7 da HSP60 parece ser um promissor peptídeo imunorregulador. O discreto aumento da sobrevida do aloenxerto de pele induzida pelo peptídeo N7 sugere que a sua combinação com imunossupressores em outros protocolos de indução de tolerância, pode ser uma estratégia útil para aumentar a sobrevida do aloenxerto / INTRODUCTION: Heat shock proteins (HSPs) are proteins present in all living beings. They have dual immunologic functional activity inducing both proinflammatory and regulatory responses. In our group, we study the immunological effects of HSP60 peptides in human and mice. OBJECTIVES: To identify potentially immunoregulatory HSP60 peptides in mice, aiming at tolerance induction in the context of alotransplantation. METHOD: We analyzed the capacity of different HSP60 peptides to modify in vitro the expression of predominantly immunoregulatory genes (Foxp3, Gata-3, IDO, IL-4, IL-10, TGF?) or inflammatory (T-bet, IL-12p35, IL-12p40, IL-17) by Real Time PCR, in naive mice splenocytes. We considered gene modifications induced by the peptides as REG (?expression of immunoregulatory genes or ?expression of inflammatory genes) or INFLAMMA (?expression of immunoregulatory genes or ? expression of inflammatory genes). We selected some promising peptides that induced predominantly REG gene expression modifications as immunoregulatory peptides, to perform in vivo assays of tolerance induction to murine skin allograft. RESULTS: More promising peptides were N7, C4, N6, I8, N2 and N3. The N7 peptide (n=9) induced a REG/INFLAMMA ratio=2,71 and induced gene expression reduction of IL-17 and IL-12p40. The C4 peptide (n=6) induced a REG/INFLAMMA ratio =1,63 and induced gene expression reduction of IL-17 and IL-12p40. The N6 peptide (n=8) induced a REG/INFLAMMA ratio =1,60, induced gene expression reduction of T-bet and IL-12p40, and increased expression of IL-10. The I8 peptide (n=5) induced a REG/INFLAMMA ratio =1,57 and induced increased gene expression of IL-17. The N2 peptide (n=8) induced a REG/INFLAMMA ratio =1,32 and induced gene expression reduction of IL-17 and increase expression of IL-10, IL-4 and T-bet. The N3 peptide (n=7) induced a REG/INFLAMMA ratio =1,25 and induced no gene expression modification highlights. The N7 peptide was tested in tolerance mice allograft induction protocols. There was no statistical difference between different groups, despite the 7-day increase in allograft survival with the protocol in combination with the ?CD3 antibody (p=0,38, n=5). DISCUSSION AND CONCLUSION: The strong immunoregulatory impact of some HSP60 peptides in the gene expression of immune molecules indicate that they may be explored for immune therapy. Despite the existence of some interindividual variability, the N7 HSP60 peptide seems to be a promising imunorregulatory peptide. The slight increase in graft survival with the N7 peptide suggests that the combination of HSP60 peptides with other immunosupressors and different tolerance induction protocols may be a way to improve graft survival.

Considerando que processos cruciais de diferenciação e maturação das células dendríticas (DCs) são regulados pelo fator de transcrição nuclear kappa B (NF-&#954;B), nos propusemos a estudar esta via em DCs derivadas de monócitos de pacientes com câncer de mama, partindo da hipótese de que alterações desta via contribuam, nesses indivíduos, para a geração de DCs com fenótipo e função alterados, levando ao escape tumoral. A análise da presença de NF-&#954;B no núcleo de monócitos, DCs imaturas (iDCs) e maduras indicou que as pacientes falham em modular tal fator de transcrição, de modo que a quantidade de NF-&#954;B no núcleo de iDCs de pacientes supera os níveis encontrados em controles, fenômeno possivelmente decorrente de alterações nas proteínas inibidoras do NF-&#954;B em pacientes. Observou-se menor frequência de células CD86+, CD83+ e HLA-DR+ (p < 0,05) ao final das culturas das pacientes, e aumento na concentração de IL-8 no sobrenadante das culturas. Coletivamente, estes dados corroboram a hipótese formulada. / Considering that crucial processes of differentiation and maturation of dendritic cells (DCs) are regulated by nuclear factor kappa B (NF-&#954;B), we proposed to study this pathway in monocyte-derived DCs from breast cancer patients, based on the hypothesis that alterations in such pathway may contribute in these individuals to the generation of DCs having phenotypic and functional changes, leading to tumor escape. The analysis of the presence of NF-&#954;B in the nucleus of monocytes, immature and mature DCs indicated that patients fail to modulate this transcription factor, so that the amount of NF-&#954;B in the nucleus of iDCs from patients exceeds levels found in controls, a phenomenon possibly due to alterations in inhibitory proteins of NF-&#954;B in patients. It was also observed diminished frequency of CD86+, CD83+ and HLA-DR+ cells (p <0.05) at the end of the patients cultures, as well as increased IL-8 concentration in the culture supernatants. Collectively, these data support the hypothesis previously formulated.